Cox Regression Analysis of Prognostic Factors of Intensity-Modulated Radiotherapy in Patients with Bladder Cancer

• Chen Su ^[1] ; Jianghua Xue ^[1] ; Ning Liu ^[1]
  1. [1] Jinan Central Hospital

     Jinan Central Hospital

     China

     
• Localización: Archivos españoles de urología, ISSN 0004-0614, Tomo 76, Nº. 6 (August), 2023, págs. 411-417
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Objective: This paper aims to explore the prognostic factors of intensity-modulated radiotherapy (IMRT) in patients with bladder cancer by Cox regression analysis and to provide evidence for prolonging the survival of patients and improving the treatment status.

    Methods: A total of 153 cases of patients with bladder cancer who received IMRT were selected as research objects, and their clinical data were retrospectively analyzed and followed up. Kaplan–Meier survival analysis was conducted to calculate the median survival period, univariate and multivariate Cox regression were used to analyze the prognostic factors of IMRT in patients with bladder cancer, and receiver operating characteristic curve was adopted to evaluate the prediction efficiency of influencing factors.

    Results: Patients were followed up for 9–40 months, and 55 patients died by the end of the follow-up. The median survival time was 30 months, and the 3-year survival rate was 64.05% (98/153). Univariate analysis showed that T stage, total cystectomy, lymph node, pathological type and hydronephrosis influenced the prognosis of IMRT for patients with bladder cancer (p < 0.05). Multivariate Cox regression analysis showed T3 stage (odds ratio (OR) = 0.149, 0.068–0.327), T4 stage (OR = 27.639, 3.677–207.758), lymph node presence (OR = 0.152, 0.050–0.467), pathological type (OR = 0.086, 0.025–0.296) and hydronephrosis (OR = 7.402, 1.161–47.192) were independent factors affecting the prognosis of IMRT in patients with bladder cancer (p < 0.05), while total cystectomy (OR = 1.037, 0.171–6.301) was not an independent factor affecting the prognosis of IMRT in patients with bladder cancer (p > 0.05).

    Conclusions: T stage, lymph nodes, nontransitional cell carcinoma with pathological type and hydronephrosis can influence the prognostic effect of IMRT in patients with bladder cancer.